Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 21.8.2023Zentiva, k.s. (ZNT-1)00858Hydrocortison Léčiva (ung 1x10 g (tuba Al))23.8.2023O
 21.8.2023Zentiva, k.s. (ZNT-1)04178Triamcinolon E Léčiva (ung der 1x20 g (tuba Al))23.8.2023O
 21.8.2023Zentiva, k.s. (ZNT-1)3049BTorvacard Novum 20 mg (tbl flm 30x20 mg (blis.OPA/Al/PVC/Al))23.8.2023O
 21.8.2023Zentiva, k.s. (ZNT-1)81775Valzap 160 mg (tbl flm 28x160 mg (blis.PVC/PE/PVDC/Al))23.8.2023O
 21.8.2023Gedeon Richter Plc. (GDN)2964ETELEXER 110 mg tvrdé kapsuly (cps dur 60x110 mg (blis.Al/Al))18.8.2023U
 21.8.2023Gedeon Richter Plc. (GDN)2965ETELEXER 110 mg tvrdé kapsuly (cps dur 180(3x60)x110 mg (blis.Al/Al-multibal.))18.8.2023U
 21.8.2023Gedeon Richter Plc. (GDN)2972ETELEXER 150 mg tvrdé kapsuly (cps dur 60x150 mg (blis.Al/Al))18.8.2023U
 21.8.2023Gedeon Richter Plc. (GDN)2973ETELEXER 150 mg tvrdé kapsuly (cps dur 180(3x60)x150 mg (blis.Al/Al-multibal.))18.8.2023U
 20.8.2023Takeda GmbH (TKD-3)2627EQdenga prášok a rozpúšťadlo na injekčný roztok v naplnenej injekčnej striekačke (plv iol 1xdávka + 1x0,5 ml solv. (liek.inj.skl.+ striek.inj.napl.skl. + 2 ihly))22.8.2023U
 20.8.2023Baxalta Innovations GmbH (BXA)1889CCuvitru 200 mg/ml (sol inj 1x10 ml (liek.inj.skl.))17.8.2023O
 20.8.2023Baxalta Innovations GmbH (BXA)1888CCuvitru 200 mg/ml (sol inj 1x5 ml (liek.inj.skl.))17.8.2023O
 18.8.2023CHEPLAPHARM Registration GmbH (CEP-2)64307ZYPADHERA 300 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním (plu igf 1x300 mg (liek.inj.skl.) +1x3 ml solv.(liek.inj.skl.))21.8.2023R
 18.8.2023Fresenius Kabi Deutschland GmbH (FRK-1)1553ESugammadex Fresenius Kabi 100 mg/ml injekčný roztok (sol inj 10x2 ml/200 mg (liek.inj.skl.))18.8.2023U
 18.8.2023Fresenius Kabi s.r.o. (FRK-CZ-3)8535CGlucose/Sodium Chloride Fresenius Kabi 2,5 %/0,45 % (sol inf 12x500 ml (fľ.skl.))18.8.2023O
 18.8.2023Zentiva, k.s. (ZNT-1)6132DAmbrisentan Zentiva 5 mg filmom obalené tablety (tbl flm 30x1x5 mg (blis.PVC/PVDC/Al-jednotliv.dáv.))31.10.2023Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)